Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

The presence of mental health, pain-related illnesses, and metabolic diseases were significantly associated with the worsening of arthritis-related pain, severity, and disease activity. 

Targeting Mental Health, Pain-Related Illnesses May Improve Outcomes in Difficult to Treat RA

Results showed treatment with dipeptidyl peptidase-4 inhibitors (DPP-4i) improved bone mineral density and reduced osteoporosis risk in patients with type 2 diabetes. 

DPP-4i Treatment Significantly Reduces Osteoporosis Risk in Patients with Type 2 Diabetes

In this late-breaking research shown at ACR 2023, TLC599 injection led to benefits in patients with a single injection and further benefits with a second.


TLC599 Injection Shown to be Effective for Daily Pain in Patients with Osteoarthritis of the Knee

In this discussion with Dr. Hunter, the findings his team presented at ACR 2023 were explored, including a discussion about their implications for the future of osteoarthritis treatment.


David Hunter, MBBS, PhD: Findings, Implications of Data Regarding TLC599 Injection for Osteoarthritis

This discussion with Dr. Hunter covered the takeaways from his team’s phase 3 findings on treatment of osteoarthritis of the knee.

David Hunter, MBBS, PhD: Phase 3 Findings on Repeat TLC599 Injection for Osteoarthritis of the Knee

Osteoporosis is estimated to affect 595 million patients worldwide, representing a 132% increase in total cases since 1990.

Osteoarthritis Affects 15% of People Over Age 30

Patients identified areas of confusion in data presentation and suggested educational support to better engage with the information provided. 

Advancing Personalized Web-Based Decision Reports for Enhanced Patient Care

The guidelines were created using a panel of rheumatologists, orthopedic surgeons, and patients. 

ACR/AAHKS Introduces Guidelines for Optimal Timing of Knee and Hip Arthroplasty 

A retrospective analysis comparing propensity score matched metformin users against sulfonylurea users, results of the study indicate metformin use was associated with a 24% reduction in relative risk of developing osteoarthritis.

Metformin Could Lower Osteoarthritis Risk in Type 2 Diabetes

“Our primary motivation was to help develop treatments for people with osteoarthritis that would slow or prevent the disease and be more than painkillers- actually affect the disease process itself,” Virginia Kraus, MD, explains. 

Biomarker Predicts Patients at Greater Risk of Worsening Knee Osteoarthritis 

On the HCPLive osteoarthritis page, resources on the topics of medical news and expert insight into OA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on degenerative joint disease, and more.